PSD-95 inhibition in neurogenerative disorders

il y a 2 ans

Avilex Pharma



Recherche partenariat

Recherche partenaire principal

Avilex Pharma has developed an exceptionally high-affinity inhibitor of the intracellular scaffolding protein, postsynaptic density protein 95 (PSD-95), which bridges the NMDA glutamate receptor and neuronal nitric oxide synthase (nNOS). Avilex Pharma is pursuing this peptide-based compound as a potential drug candidate for the treatment of ischaemic stroke and seeks partners to evaluate these in in vitro and in vivo models of stroke and other related neurodegenerative conditions.

 Entrepreneuriat et PME
 Soins de santé
 Sciences Biologiques
 Innovation & Recherche

Appels recommandés pour cette idée
Si vous connaissez un appel qui peut correspondre à cette idée

Recommander un appel